Text and Data Mining valid from 2018-06-25
Received: 24 November 2017
Accepted: 19 June 2018
First Online: 25 June 2018
Ethics approval and consent to participate
: Consent for participation of were obtained from all patients in this study. The study protocol was approved by the Conjoint Health Research Ethics Board at the University of Calgary (Calgary, Alberta Canada).
: Consent for publication was obtained from all patients in this study.
: MJF has been a consultant to Inova Diagnostics (San Diego, CA), Werfen International (Barcelona, Spain) and BioRad (Hercules, CA, USA). He has also received gifts in kind from Euoimmun GmbH (Luebeck, Germany).MGS has served as a speaker and/or advisory board member and/or has received research support from Allergan, Genfit, Bristol Myers Squibb, Gilead Sciences, CymaBay Therapeutics, Abbott, Intercept Pharmaceuticals, Genkyotex, Novartis, Glaxo Smith Kline, Abbvie and Merck. He has served as a data and safety monitoring committee member in clinical trials for Gilead Sciences and GRI Bio Inc. MGS also holds the Cal Wenzel Family Foundation Chair in Hepatology. HHN and AK have no disclosures or competing interests to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.